A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 6/23/2010

Posted by | 4:42pm on Wednesday, June 23, 2010

:
cadelarge here from novonordisk. what we talking about tonight? #socpharm 6/23/2010 18:59

:
Good evening everyone Rich Meyer Passionate DTC marketer ready to learn more #socpharm 6/23/2010 19:00

:
Welcome to pharma marketing & social media tweetchat #socpharm Please introduce yourself… 6/23/2010 19:00

:
#socpharm Dan here from theclinicaltrialsguru.com looking fwd to this 6/23/2010 19:01

:
I’m Eileen & love my job at Siren Interactive where we focus on relationship marketing for #raredisorders. #socpharm. 6/23/2010 19:01

:
We’ll assume that all tweets within #socpharm are your own and not your employers (unless you specifically declare them) 6/23/2010 19:03

:
I’m Lexie from Ketchum Digital where we focus mostly on #sm & #digital for B2B & corporate / internal communications. #socpharm 6/23/2010 19:03

:
Hello everyone & @! Angela Dunn, Dir of Social Media 4 @. Excited 2 talk about innovation in #pharma mktg #socpharm 6/23/2010 19:03

:
Carmen Gonzalez, Mgr. of Strategy & Communication at HCG; I create clinical trial recruitment plans and social media solutions #socpharm 6/23/2010 19:03

:
So I crowdsourced the #socpharm topics for tonight & you smart people came up with some interesting ones. 6/23/2010 19:03

:
Joel here from @, looking forward to another insightful #socpharm chat 6/23/2010 19:03

:
@ good webinar today Carmen #socpharm 6/23/2010 19:04

:
Hey! My name is Drew Slater and I am recent PR graduate from USF. I’m currently trying to learn everything about social media! #socpharm 6/23/2010 19:05

:
@ when you finish learning everything, we will enroll in your school. :-) Welcome! #socpharm 6/23/2010 19:06

:
@ Great initiative participating in #socpharm! #socpharm 6/23/2010 19:07

:
Welcome everyone! I thought I’d start by saying #socpharm has been around for 6 months & thanking everyone for their support, it’s been fun. 6/23/2010 19:07

:
T1: @ brought attention to new Google DoubleClick ad planner w/script that follow u http://bit.ly/bTOOYV Lexie Can u explain? #socpharm 6/23/2010 19:08

:
@ Thank you, Eileen for providing this forum for great exchanges and information! #socpharm 6/23/2010 19:08

:
I can really see that in the last 6 months pharma has come a long way in social media! #socpharm 6/23/2010 19:10

:
Thank you @ @ !! #socpharm 6/23/2010 19:10

:
Basiscally looks at other sites and recommends sites to run your ads #socpharm 6/23/2010 19:10

:
RT @: Happy to explain after #Google bought Double Click, they cultivated an advanced ad-buy/serving network to track targets #socpharm 6/23/2010 19:10

:
How big of an impact do Facebook ads truly have? #socpharm 6/23/2010 19:10

:
So re: #SocPharm, the new Google DoubleClick Ad Planner system is “illegal” for #DTC but allowed for #DTP bc of privacy & anonymity reasons 6/23/2010 19:11

:
@ what’s ur definition of impact? #socpharm 6/23/2010 19:11

:
@ When you say “illegal” u mean DoubleClick won’t let you do it for DTC ads? #socpharm 6/23/2010 19:12

:
Just curious when’s the last time anyone clicked on a Facebook ad or an ad anywhere else- is it about clicking or just reading? #socpharm 6/23/2010 19:12

:
@ why illegal for DTC but not for DTP? #socpharm 6/23/2010 19:12

:
Interesting to look at click stream analysis for any pharma site and see that consumer go to your competitors sites as well #socpharm 6/23/2010 19:12

:
positive results?? Do you think ppl really pay attention to them? #socpharm 6/23/2010 19:12

:
@ I clicked on several FB ads just today. They feed me stuff I am interested in. #socpharm 6/23/2010 19:12

:
RT @: @ When you say “illegal” u mean DoubleClick won’t let you do it for DTC ads? #socpharm 6/23/2010 19:12

:
@ Facebook ads have very low click thru in my exper #socpharm 6/23/2010 19:13

:
@ illegal for DTC because of anonymity issues re: #health data spread to the internet vs. DTP where we know it’s a career #socpharm 6/23/2010 19:13

:
@ Don’t all online ads have low CTRs? But that is low relative to what? #socpharm 6/23/2010 19:14

:
@ Recently for rare disease FB ads got some nice results accessing hard to reach target. #socpharm 6/23/2010 19:14

:
RT @ illegal 4 DTC because of anonymity issues re: #health data spread 2 Internet vs. DTP where we know it’s a career #socpharm 6/23/2010 19:14

:
@ @ yes “illegal” in that #GoogleDoubleClick will not allow DTC following. not (yet) a DDMAC or #FDA issue #socpharm 6/23/2010 19:14

:
@ Have you seen the Nielsen study on FB ads? #socpharm 6/23/2010 19:14

:
@ Not necess..if you use behavorial targeting CTR goes up #socpharm 6/23/2010 19:14

:
@ What do you mean by “we know its a career?” #socpharm 6/23/2010 19:15

:
@ No I haven’t actually…Do you by chance have a link? #socpharm 6/23/2010 19:15

:
However click thru means nothing its cost per targeted action #socpharm most sites have high bounce rates 6/23/2010 19:15

:
@ @ i never click on #FB ads except to say “please dont show me this type of ad again.” FB CTR is notably low. #socpharm 6/23/2010 19:16

:
Think of this: An consumer who clicks on your ad is saying “tell me more” but bounce rates are high because…#socpharm 6/23/2010 19:16

:
@ what is definition of bounce rate as you use it here? One clicks but does drops off after that one click? #socpharm 6/23/2010 19:17

:
@ http://tinyurl.com/ybtzeqh #socpharm 6/23/2010 19:17

:
@ Wow! Thank you so much! #socpharm 6/23/2010 19:17

:
@ for DTP following them has no privacy concerns. re: they are physicians so their own anonymity is not an issue #socpharm 6/23/2010 19:17

:
@ Isnt FB targeting a form of behavioral targeting, or just contextual? #socpharm 6/23/2010 19:18

:
@ When they come to your homepage they bounce from your site because they are not interested in your site #socpharm 6/23/2010 19:18

:
@ @ I have to say that a lot of Nielsens findings are questionable at best #socpharm 6/23/2010 19:18

:
@ No not behavioral at all #socpharm 6/23/2010 19:19

:
Have run some facebook ads and found it can work you just need to be very thoughtful with how you do it and what you say #socpharm 6/23/2010 19:19

:
@ @ FB targeting is contextual not behavioral to my knowledge. but interested in info otherwise #socpharm 6/23/2010 19:19

:
@ How come?..I guess it is good to know as much as info as I can to make a conclusion though #socpharm 6/23/2010 19:20

:
Thanks Steve! RT @ Nielsen/ #Facebook Report: The Value of Social Media Ad Impressions http://tinyurl.com/ybtzeqh #socpharm 6/23/2010 19:20

:
@ Tell us more, I thought this work was pretty solid #socpharm 6/23/2010 19:20

:
@ how do you define distinction btw behav and context targeting? #socpharm 6/23/2010 19:20

:
@ – isn’t that bounce in some ways due to a site being a branded (product) versus unbranded or condition site #socpharm 6/23/2010 19:20

:
@ Sounds like you should write a blog post about this topic. #socpharm 6/23/2010 19:20

:
@ @ @ – I concur re: Nielsen’s findings. hard to strip their own interests from the actual “news” #socpharm 6/23/2010 19:20

:
@ agreed, that is why much advertising fails. lack of insight and proper thought. #socpharm 6/23/2010 19:20

:
If you know your niche & can target specific keywords, FB ads can be effective for cost. #socpharm 6/23/2010 19:20

:
I feel like companies should make ads because they are low cost with a huge potential audience. What is there to lose really? #socpharm 6/23/2010 19:20

:
@ that’s interesting – I rarely get #fb ads I’m interested in, mostly junk or religious stuff owing to my surname, sigh #socpharm 6/23/2010 19:20

:
@ we were just talking new Google doubleclick DTP allowed following through their ad network, banned for DTC. thoughts? #socpharm 6/23/2010 19:21

:
@ @ the difference btw behavioral & contextual is contextual is keyword based & behavioral is harder to capture #socpharm 6/23/2010 19:22

:
@ OK first I believe that our ability to measure behavior is badly flawed because everything happens to fast today #socpharm 6/23/2010 19:22

:
RT @: @ How come?..I guess it is good to know as much as info as I can to make a conclusion though #socpharm 6/23/2010 19:22

:
@ Recetnly Nielsen said that older consumers tend to multi-task while watching TV? I dont buy that at all #socpharm 6/23/2010 19:23

:
@ Younger people are always multitasking while watching TV #socpharm 6/23/2010 19:23

:
@ http://is.gd/d1eja #socpharm 6/23/2010 19:24

:
Agreed RT @ If you know your niche & can target specific keywords, FB ads can be effective for cost. #socpharm 6/23/2010 19:24

:
joining late tonight! #socpharm 6/23/2010 19:24

:
main concern regarding GDCAP (google doubleclick ad planner) is that it blasts HCPs wherever they go online w/o context. thoughts? #socpharm 6/23/2010 19:24

:
Topic 2 via @: R ur peers in clin/reg/safety knowledgeable re: hcsm to date? How can we share knowledge/bridge gaps? #socpharm 6/23/2010 19:26

:
@ sorry GDCAP is hard to explain! it comes down to a privacy issue. do HCPs not deserve browsing privacy too? #socpharm 6/23/2010 19:27

:
@ ANd so does Gen X and Y in fact they are always multitasking even during sex ! #socpharm 6/23/2010 19:27

:
@ Hello stranger, great to see you! #socpharm 6/23/2010 19:27

:
@ thanks. I think Nielsen measures PC usage at home only, not at work #socpharm 6/23/2010 19:27

:
@ Why can’t u buy older consumer multi-task? What evidence to contrary other than our bias re: assum behav of old adults? #socpharm 6/23/2010 19:28

:
@ sounds almost like spam #socpharm 6/23/2010 19:28

:
@ And Internet usage by PC not mobile devices #socpharm 6/23/2010 19:28

:
T2: Not many are familiar with HCSM, but now with more SM topics at conferences and webinars, they are seeking info out #socpharm 6/23/2010 19:28

:
Hey everyone! Nice meeting ya’ll. I gotta check out early tonight. Sry. But I’ll be back next time. #socpharm 6/23/2010 19:28

:
thanks !trying to catch up! RT @: @ Hello stranger, great to see you! #socpharm 6/23/2010 19:29

:
@ my peer’s knowledge of HCSM is growing on need to know basis. I have kit I use to help them. #socpharm 6/23/2010 19:29

:
@ Dont get me wrong I am sure they do I just dont believe they do it more than younger consumers #socpharm 6/23/2010 19:29

:
@ I don’t buy that either, can understand younger generations multi-tasking w/ tv but not older gen #socpharm 6/23/2010 19:29

:
@ not spam outright bc it could come in handy — Hi doc, we see u left brand.com to webMD want more info about product? #socpharm 6/23/2010 19:29

:
@ …but why don’t you buy it? #socpharm 6/23/2010 19:30

:
T2: Best way to inform peers on HCSM is to showcase value in a case study you participated in and can vouch for #socpharm 6/23/2010 19:30

:
@ Agree, I met a few regulatory/legal folks at Social Media event the other week. #socpharm 6/23/2010 19:31

:
@ Google doubleclick reminds me of olde Y! Program did the same thing…results were not the same as ‘prime inventory’ #socpharm 6/23/2010 19:31

:
it’s all too common that we stereotype generational #technology use! Everyone multitasks w/ TV, not just #GenY! #socpharm 6/23/2010 19:31

:
Yes I found at DIA there were many safety & reg & clin folks seeking how can we use in the social media accelerator tutorial #socpharm 6/23/2010 19:31

:
@ Right, not spam, but more like OOH, high reach, minimal targeting? #socpharm 6/23/2010 19:32

:
Best way to showcase social media is to start an internal campaign first. #socpharm 6/23/2010 19:32

:
I used Nielsen BLOG Pulse before + its good but their generic information I question #socpharm because it just doesnt jive with what I know 6/23/2010 19:32

:
RT @ Best way to showcase social media is to start an internal campaign first. #socpharm 6/23/2010 19:32

:
Joining late, but caught up. Are their any branded #pharma FB ads that we are referencing? Or is this just in general? #socpharm 6/23/2010 19:32

:
@ haha! it reminds me of that too! interesting some pharmacos believe in potential for RX increase w/ it though? #socpharm 6/23/2010 19:33

:
Topic 2: R ur peers in clin/reg/safety knowledgeable re: hcsm to date? How can we share knowledge/bridge gaps? #socpharm 6/23/2010 19:33

:
Did everyone see the data that showed that pharma pages were among the least liked of Facebook pages #socpharm 6/23/2010 19:34

:
T2: we’re launching a new hands-on, social media workshop series this summer w/ simulations to let them experience SM first hand #socpharm 6/23/2010 19:34

:
RT @: Best way to showcase social media is to start an internal campaign first. #socpharm 6/23/2010 19:34

:
@ Just talking generally about experience with Facebook ads. #socpharm 6/23/2010 19:34

:
@ T1: haha! high reach, moderate targeting mabye? bc GDCAP grabs #IP for anyone on HCP side of a brand.com & follows it #socpharm 6/23/2010 19:35

:
I won’t say the doubleclick idea is bad hood legal illegal but it’s easy to screw up if your very direct about your message #socpharm 6/23/2010 19:35

:
RT @: T2: we’re launching new hands-on, social media workshop series this summer w/simulations 2 experience SM first hand #socpharm 6/23/2010 19:35

:
@ agreed! #hcsm is on a need to know basis. Too much interest in specifics. #socpharm 6/23/2010 19:36

:
@ I’d love the link on the unsatisfactory response to pharma FB pages. can you share? Thanks. #socpharm 6/23/2010 19:36

:
@ no, do you have a ref for that, Rich? Quite believable! #socpharm 6/23/2010 19:36

:
Nice! RT @: T2: we’re launching new hands-on, sm workshop series this summer w/simulations to let them experience SM 1sthand #socpharm 6/23/2010 19:36

:
@ Pls share link to research about pharma FB being disliked. Thanks. #socpharm 6/23/2010 19:36

:
T1: one problem w/ GDCAP is that it grabs IP for anyone browsing HCP side of a brand.com #socpharm– which we know is often consumers! 6/23/2010 19:36

:
All good ideas must die…so that great ones can live !! #socpharm 6/23/2010 19:36

:
RT @ T2: we are launching a new hands-on, SM workshop series this summer w/ simulations to let them experience SM first hand #socpharm 6/23/2010 19:36

:
@ I find it helps to increase the # of “need to know” bases by proposing more programs. :-) #socpharm 6/23/2010 19:37

:
@ Is that because most the pharma FB pages don’t truly interact w/people yet? Or because pple don’t like/trust pharma? #socpharm 6/23/2010 19:37

:
@ http://is.gd/d1f7T #socpharm From Hubspot 6/23/2010 19:38

:
cool…would be gr8 to also have teams participate 2gether so can learn real time @: T2: we’re launching SMworkshop series #socpharm 6/23/2010 19:38

:
Yes, @. Do you think that’s because of the “branded” pages that are active on FB? Or is it #pharma branded or unbranded.#socpharm 6/23/2010 19:38

:
it is all about the positioning 4 #pharma, @ has 114,000+ fans: http://www.facebook.com/takeastepagainstcervicalcancer #socpharm 6/23/2010 19:38

:
@ excellent question Eileen. I believe its because of the way people use Facebook #socpharm 6/23/2010 19:39

:
@ I just purchased a new Trek bike and friended them on Facebook to share with other riders #socpharm 6/23/2010 19:39

:
@ are the workshops for DRs only or pharma personnel as well? #socpharm 6/23/2010 19:39

:
@ How many people want others to know they are depressed or have other illnesesses or want to become fans of pharma? #socpharm 6/23/2010 19:39

:
T2 @ – Definitely seeing an increased interest and understanding of #hcsm just lagging far behind other industries. #socpharm 6/23/2010 19:40

:
@ Epsilon, March 2010 study: 13% of consumers believed that pharma could add credibility to health content online #socpharm 6/23/2010 19:40

:
@ T1: exactly. & now GDCAP will track browsing for DAYS. so if a client wants to power-push RX it looks appealing. #socpharm 6/23/2010 19:40

:
in order to engage in sm you first need to listen…for many pharmas that’s 3 months to get off the ground #socpharm 6/23/2010 19:40

:
There might be opp to unite people against certain diseases like caregivers of Alzeimers patients but not for pharma in gen #socpharm 6/23/2010 19:41

:
@ Not many want ppl to know about depression & other illness but I think FB is for those who dont care. SL for anonymous. #socpharm 6/23/2010 19:41

:
@ exactly, that’s why our workshops will be conducted on-site for internal biopharma teams #socpharm 6/23/2010 19:41

:
Here is the link to Hubspot blog on least likes pages in FB #socpharm http://is.gd/d1fjD 6/23/2010 19:41

:
@ @ to be fair though, #Gardasil started out as a very early #facebook adopter so their fan numbers are high #socpharm 6/23/2010 19:42

:
@ I agree re: listen first. This is a new competency for many marketers. We are better at telling than listening. #socpharm 6/23/2010 19:42

:
Not sure its all conscious decision about pharma as much as most FB’s doesn’t add value to their lives @: @ #socpharm 6/23/2010 19:42

:
@ @ yes that is an excellent example because it is preventative and controversial #Gardasil #facebook #socpharm 6/23/2010 19:42

:
@ Many pharma companies are active in SM. Check out the later slides to this PPT http://bit.ly/cm2HqO #socpharm 6/23/2010 19:43

:
@ Epsilon study is fascinating. Sad that pharm is low, but nonprofit orgs r high so partner: http://bit.ly/cupe6L #socpharm 6/23/2010 19:43

:
@ the workshops are designed for pharma personnel, we’ve developed program simulations & a new training site #socpharm 6/23/2010 19:43

:
@ Actually research shows otherwise that people do care. We saw even diabetics dont want people to know they have #socpharm 6/23/2010 19:43

:
@ Actually, although they started early, believe @‘s success was in branding their page 4 a cause & not the drug. #socpharm 6/23/2010 19:43

:
@ @ good point Ellen.That is the key, if there is value than people will join but that value has to be #socpharm 6/23/2010 19:44

:
@ great! thanks for the clarity #socpharm 6/23/2010 19:44

:
Is the #gardasil success linked to their target? It’s also not called Facebook.com/gardasil, does that help? #socpharm 6/23/2010 19:44

:
@ Those that care dont, those that dont care do. :-) #socpharm 6/23/2010 19:44

:
RT @: @ YES, that’s key. partner with 3rd party patient advocacy for credibility/rich : http://bit.ly/cupe6L #socpharm 6/23/2010 19:45

:
Also new study showed that 75% of comps are using social media but only 41% have strategy ?? #socpharm 6/23/2010 19:45

:
@ exactly! #socpharm 6/23/2010 19:45

:
At least! RT @: in order 2 engage in sm U 1st need 2 listen…for many pharmas that’s 3 months 2 get off the ground #socpharm 6/23/2010 19:45

:
T3: Via @ interested in CRO/manuf companies going social. What r ways for them to make best of it? #socpharm 6/23/2010 19:46

:
@ Not necessarily diabetics from our research dont necess want others to know they have diabetes stigma attached #socpharm 6/23/2010 19:46

:
@ @ makes good point re: branding as cause (which Gardasil did) but it gets murky w/ promotional msgs mixed in #socpharm 6/23/2010 19:46

:
@ Especially Type 1 who dont like being lumped in with Type 2 #socpharm 6/23/2010 19:46

:
Hi #socpharm peeps. Frieda Hernandez from Siren Interactive here. Trying to get caught up on the great convo! 6/23/2010 19:46

:
@ Fair and some (few) of those concerned about stigma are going onto virtual worlds like SecondLife for support. #socpharm 6/23/2010 19:47

:
link? what study? RT @ Also new study showed that 75% of comps are using #socialmedia but only 41% have strategy ?? #socpharm 6/23/2010 19:48

:
RT @: T3: Via @ interested in CRO/manuf companies going social. What r ways 4 them 2 make best of it? #socpharm 6/23/2010 19:48

:
@ As to T1s its nice to see that they have their own communities that allow when to bond separate from T2s. #socpharm 6/23/2010 19:48

:
@ @ @ Also Gardasil page is updated sporadically which is not good when you talk SM #socpharm 6/23/2010 19:48

:
why do people hat the “s” word? @: new study showed that 75% of comps r using social media but only 41% have strategy? #socpharm 6/23/2010 19:49

:
@ Agreed. Some of the more successful examples are pharma partnerships with patient groups (e.g. PKU, CFVoice, etc) #socpharm 6/23/2010 19:49

:
@ @ #SecondLife is amazing in that way but creating an engaged user base can be hard vs. easier @ #socpharm 6/23/2010 19:49

:
@ Study from Digital Brand Expressions just Google to download #socialmedia #socpharm 6/23/2010 19:49

:
T3: @ as noted by others, listening is gr8 first step. #socpharm 6/23/2010 19:50

:
@ @ – pretty sure #Gardasil‘s “sporadic” updates are related to Merck’s approval timing not lack of strategy #socpharm 6/23/2010 19:50

:
Here is URL for info on not using strategy for SM #socpharm http://is.gd/d1fOu 6/23/2010 19:50

:
Might as well throw darts!: Of companies using social media, only 41% say they have a strategic plan http://tinyurl.com/2bva32p #socpharm 6/23/2010 19:51

:
T3: and in addition to listening to conversation, sentiment analysis is a great first step to determining strategic direction #socpharm 6/23/2010 19:51

:
@ @ yeah so therefore people are not using like they should #Gardasil #socpharm 6/23/2010 19:52

:
Final topic: Do you think innovation a dirty word in pharma marketing? #socpharm 6/23/2010 19:52

:
T2: It’s all about knowing your target audience and employing sound SM strategy; that’s why collaboration across functions key #socpharm 6/23/2010 19:52

:
Like Aretha Franklin says “You better think” #socpharm 6/23/2010 19:52

:
@ I dont think innovation is dead but def on life support. People too afraid to be LInchpins #socpharm 6/23/2010 19:53

:
@ Innovation is not a dirty word. It has more than 4 letters. #socpharm 6/23/2010 19:53

:
T4 @ no! Innovation is the key to success until there is true guidance from the FDA! #socpharm 6/23/2010 19:53

:
Dirty or non existent? :-( @: Final topic: Do you think innovation a dirty word in pharma marketing? #socpharm 6/23/2010 19:54

:
FTopic: if an invitation is required before experimenting with a new medium, then all novel platform use would be considered rude. #socpharm 6/23/2010 19:54

:
One reason I love working in #raredisease space is that marketers are willing to innovate & sometimes have to in order to succeed #socpharm 6/23/2010 19:55

:
Pharma innovation is not dead, just incremental, versus discontinuous. #socpharm 6/23/2010 19:55

:
Tough to innovate when regs have final say #socpharm 6/23/2010 19:55

:
RT @: @ Agreed-some of more successful examples are pharma partnerships w/patient groups (e.g. PKU, CFVoice… #socpharm 6/23/2010 19:55

:
I think “innovation” isn’t a dirty word in #healthcare– it’s a loaded one. Everyone wants risk-free innovation #SocPharm 6/23/2010 19:56

:
@ Few orgs or organisms innovate unless perceiving near death experience. #socpharm 6/23/2010 19:56

:
It has become an unassailable tenet of business: Companies must Always Be Innovating #socpharm 6/23/2010 19:56

:
RT @ I love working in #raredisease space because marketers innovate & sometimes have to in order to succeed (So true) #socpharm 6/23/2010 19:56

:
RT @ 1 reason I love working in #raredisease is marketers are willing 2 innovate & sometimes have 2 in order 2 succeed #socpharm 6/23/2010 19:57

:
Although much inno takes place in finance, which of course is regulated (?) as well #socpharm 6/23/2010 19:57

:
It may not be dead but it needs a jolt :) RT @ Pharma innovation is not dead, just incremental, versus discontinuous. #socpharm 6/23/2010 19:57

:
Want more innovation? Find more “near-death experiences” and show them to those who would care. #socpharm 6/23/2010 19:57

:
Sometimes innovation is confused with being provocative. Attention-getting + impactful results = innovation #socpharm 6/23/2010 19:58

:
@ and that is why regulation is a poor excuse. #socpharm 6/23/2010 19:58

:
RT @: Sometimes innovation is confused with being provocative. Attention-getting + impactful results = innovation #socpharm 6/23/2010 19:59

:
@ Re: Hubspot study – the graph charts only groups that have below the 600 FB fan avg. Pharma on the high end w/500 avg #socpharm 6/23/2010 19:59

:
@ Innovation (actually change of any kind) can be painful. #socpharm 6/23/2010 19:59

:
@ Innovation is also accepting you may fail, and still going forward. #socpharm 6/23/2010 19:59

:
Next Wed is the last of the quarter & we switch up #socpharm to the morning for EU tweeps. So 8 AM EST/7 am CST/ 6 am PST. Please join us. 6/23/2010 19:59

:
Exactly! @ @ and that is why regulation is a poor excuse. #socpharm 6/23/2010 20:00

:
All innovation comes with risk. It’s whether the reward is greater and with #hcsm the ROI isn’t defined. #socpharm 6/23/2010 20:00

:
Thanks again everyone for a fascinating hour! I’ll post the transcript on http://socialpharmer.ning.com/ #socpharm 6/23/2010 20:00

:
@ I joined the #HCSMEU a few weeks ago on Friday AM at 7am and it was nice. #socpharm 6/23/2010 20:01

:
@ but still relevant #socpharm 6/23/2010 20:01

:
RT @: Next Wed-last of quarter & we switch up #socpharm 2 the morning 4 EU tweeps. So 8 AM EST. Please join us. #socpharm 6/23/2010 20:01

:
@ Most of the ROI of learning at first is LEARNING! #socpharm 6/23/2010 20:01

:
@ thank you #socpharm 6/23/2010 20:01

:
@ I’m NOT a morning person I’m a night owl but once a quarter it works :) #socpharm 6/23/2010 20:02

:
RT @: All innovation comes with risk. It’s whether the reward is greater and with #hcsm the ROI isn’t defined. #socpharm 6/23/2010 20:02

:
Agree! RT @: @ Innovation is also accepting you may fail, and still going forward. #socpharm 6/23/2010 20:03

:
@ Thansk for your leadership on this engaging chat! #socpharm 6/23/2010 20:03

:
yes! RT @: Thank you to all for an interesting conversation & exchange, @! #socpharm 6/23/2010 20:03

:
RT @ Thank you to all for an interesting conversation & exchange, @! #socpharm 6/23/2010 20:03

:
RT @: Sometimes innovation is confused with being provocative. Attention-getting + impactful results = innovation #socpharm 6/23/2010 20:04

:
RT @: Sometimes innovation is confused with being provocative. Attention-getting + impactful results = innovation #socpharm 6/23/2010 20:04

:
@ thanks again for hosting another enjoyable #socpharm chat 6/23/2010 20:05

:
great convo as usual, thanks all #socpharm 6/23/2010 20:05

:
@ Hope you’ll join us again. Each month #socpharm has a guest moderator from a pharma company which also switches it up! 6/23/2010 20:05

:
Great convo and getting better all the time! Thanks @ and #socpharm friends. 6/23/2010 20:06

:
RT @: One reason I love working in #raredisease space is that marketers are willing to innovate & sometimes have to in order to succeed #socpharm 6/23/2010 20:06

:
Round 2! RT @: Celebrating pharma/healthcare Twitter women http://bit.ly/9NSHiY #socpharm #epharma 6/23/2010 20:07

:
I agree but hard to sell to pragmatists. RT @: @ Most of the ROI of learning at first is LEARNING! #socpharm 6/23/2010 20:08

:
@ Thanks for a great #SocPharm! Really enjoyed all the topics. :) 6/23/2010 20:10

:
Sorry I meant most of ROI of SM is learning. #socpharm 6/23/2010 20:15

:
@ also experience it hands-on. Curiosity & exploration a plus to witness first hand what the platforms are capable of #socpharm 6/23/2010 20:17

:
@ great stuff! Are you prioritizing specific platforms? Have you gathered insights on what HCPs want to learn to use most? #socpharm 6/23/2010 20:23

:
I agree with both statements :-) RT @: Sorry I meant most of ROI of SM is learning. #socpharm 6/23/2010 20:26

:
@ agree – exposure and building experience with platforms is key. #socpharm 6/23/2010 20:27

:
Thank you Time Warner for ruining such important #socpharm for me. Now I have to spend the rest of the evening reading hashtag down to 8pm 6/23/2010 20:30

:
@ @ thank you very much for raising the Q! will read all #socpharm tweets. It just wasnt my luck with Internet tonight( 6/23/2010 20:50

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com